| Autoimmune phenomena following SARS-CoV-2 vaccination Y Ishay, A Kenig, T Tsemach-Toren, R Amer, L Rubin, Y Hershkovitz, ... International immunopharmacology 99, 107970, 2021 | 82 | 2021 |
| A personalized signature and chronotherapy-based platform for improving the efficacy of sepsis treatment A Kenig, Y Ilan Frontiers in Physiology 10, 505732, 2019 | 48 | 2019 |
| Introducing variability in targeting the microtubules: Review of current mechanisms and future directions in colchicine therapy E Forkosh, A Kenig, Y Ilan Pharmacology Research & Perspectives 8 (4), e00616, 2020 | 47 | 2020 |
| Phosphorylation of ribosomal protein S6 mediates mammalian target of rapamycin complex 1–induced parathyroid cell proliferation in secondary hyperparathyroidism O Volovelsky, G Cohen, A Kenig, G Wasserman, A Dreazen, O Meyuhas, ... Journal of the American Society of Nephrology 27 (4), 1091-1101, 2016 | 41 | 2016 |
| Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products A Kenig, Y Ishay, F Kharouf, L Rubin Clinical Immunology 227, 108723, 2021 | 32 | 2021 |
| Improving diuretic response in heart failure by implementing a patient-tailored variability and chronotherapy-guided algorithm A Kenig, Y Kolben, R Asleh, O Amir, Y Ilan Frontiers in Cardiovascular Medicine 8, 695547, 2021 | 31 | 2021 |
| Increased rates of idiopathic inflammatory myopathies during the COVID-19 pandemic: a single-centre experience F Kharouf, A Kenig, E Bohbot, L Rubin, H Peleg, O Shamriz Clin Exp Rheumatol 41 (2), 316-21, 2023 | 10 | 2023 |
| Incidence and course of COVID-19 hospitalizations among patients with familial Mediterranean fever F Kharouf, Y Ishay, A Kenig, M Bitan, E Ben-Chetrit Rheumatology 60 (SI), SI85-SI89, 2021 | 10 | 2021 |
| An immunocompetent patient with culture-negative multiple brain abscesses caused by Fusobacterium nucleatum A Kenig, A Kessler, S Alaa, W Hazu, A Michael-Gaygo, S Amit, ... Anaerobe 65, 102261, 2020 | 7 | 2020 |
| Hospital-onset adult invasive pneumococcal disease in Israel: Sicker patients, different pathogens A Kenig, G Regev-Yochay, S Khakshoor, R Cohen-Poradosu, J Bishara, ... International Journal of Infectious Diseases 85, 195-202, 2019 | 5 | 2019 |
| Use of Colchicine for Pericardial Inflammation: Risks and Toxicities—A Cautionary Tale O Perzon, A Kenig, Y Fellig, D Mevorach Case Reports 4 (21), 1449-1452, 2022 | 3 | 2022 |
| Autoimmune Diseases Induced or Exacerbated by COVID-19: A Single Center Experience Y Ishay, A Kenig, L Rubin, O Shamriz, F Kharouf Autoimmune Diseases 2022, 2022 | 2 | 2022 |
| Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic Inflammation A Kenig, T Keidar-Haran, H Azmanov, A Kessler, Y Kolben, T Tayri-Wilk, ... Inflammation 46 (3), 963-974, 2023 | 1 | 2023 |
| Massive Intestinal Bleeding in an Adult with IgA Vasculitis Treated with Intravenous Immunoglobulin I Nassereddin, A Kenig, Y Ishay, H Lehmann, N Hurvitz, N Elkhateeb, ... Case Reports in Rheumatology 2022, 2022 | 1 | 2022 |
| An Adult with Recurrent Severe Pneumococcal Pneumonia Secondary to Prolidase Deficiency. A Kenig, O Perzon, Y Tal, S Sviri, A Abutbul, M Romain, ... The Israel Medical Association Journal: IMAJ 23 (3), 193-195, 2021 | 1 | 2021 |
| Blood cultures of adult patients discharged from the emergency department—is the safety net reliable? A Kenig, S Salameh, Y Gershinsky, S Amit, S Israel European Journal of Clinical Microbiology & Infectious Diseases 39, 1261-1269, 2020 | 1 | 2020 |
| Serum Levels of Adropin Improve the Predictability of MELD and Child-Pugh Score in Cirrhosis: Results of Proof-of-Concept Clinical Trial Y Kolben, A Kenig, A Kessler, Y Ishay, S Weksler-Zangen, M Eisa, Y Ilan Transplant International 36, 11176, 2023 | | 2023 |
| Colchicine at a Low Dose Reduces Liver Inflammation in a Model of Immune-Mediated Hepatitis H Azmanov, T Keidar-Haran, A Kenig, A Kessler, Y Kolben, ... Archives of Clinical and Biomedical Research 7, 215-223, 2023 | | 2023 |
| Characteristics of endovascular pneumococcal infections; a decade of nationwide surveillance study A Kenig, Y Oster, R Cohen-Poradosu, K Reisenberg, A Wieder-Finesod, ... European Journal of Clinical Microbiology & Infectious Diseases 41 (11 …, 2022 | | 2022 |
| Codivir suppresses SARS-Cov-2 viral replication and stabilizes clinical outcome: In vitro and Phase I clinical trial results Y Kolben, E Finkelshtein, E Naftali, A Kenig, A Kessler, F Cardoso, ... Discoveries 10 (4), 2022 | | 2022 |
